US Patent Issued to The Medical College of Wisconsin, Aix-Marseille Universite on April 7 for "Mitochondria-targeted atovagone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug" (American, French Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,283, issued on April 7, was assigned to The Medical College of Wisconsin Inc. (Milwaukee) and Aix-Marseille Universite (Marseilles, France).

"Mitochondria-targeted atovagone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug" was invented by Balaraman Kalyanaraman (Milwaukee), Gang Cheng (Milwaukee) and Micael Joel Hardy (Nimes, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides novel mitochondria-targeted Atovaquone compounds (Mito-ATO), a mitochondria-targeted derivative of Atovaquone, and methods of using such compounds. Methods of treating cancer using mito-ATO are also provided. M...